As for the usefulness of WT1 monitoring as an MRD marker in genetic variant cases, we investigated a case of NPM1-mutated AML enrolled in the present study with regard to the usefulness of WT1 monitoring as an MRD marker instead of the measurement of the NPM1 levels. This evidence concerns the gene WT1 and acute myeloid leukemia.